Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Steroid hormone receptor ERR1 (ERRα) is a member of the nuclear receptor family of transcription factors. It regulates genes involved in mitochondrial biogenesis, energy metabolism, fatty acid oxidation, and steroidogenesis. It does not bind estrogens but can be modulated by synthetic compounds. ERRα plays a role in cancer biology, particularly in promoting migration, invasion, and angiogenesis of breast cancer stem cell-like cells.
Binds to estrogen-related response elements (ERRE) and modulates transcription of target genes; interacts with coactivators such as PGC-1α to enhance transcriptional activity. Synthetic agonists can modulate conformation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Steroid hormone receptor ERR1 (ERRα).